NOTE: This is a Forecasted Opportunity.
The Office on Women’s Health anticipates the availability of funds to support grants focusing on postpartum deaths due to drug overdose. OWH anticipates funding applications for projects designed to strengthen perinatal and postnatal support structures for women with substance use disorder (SUD) and reduce deaths during the perinatal and postpartum periods due to drug overdose. For the purposes of this initiative, maternal deaths due to overdose are defined as death in the perinatal or postpartum period due to SUD.
OWH plans to invite applicants to: (1) Partner with hospital and community-based organizations to implement evidence-based interventions that strengthen perinatal and postpartum support structures for women with substance use disorders; (2) Improve health outcomes and reduce deaths during the perinatal and postpartum time periods due to drug overdose; (3) Create technologically innovative education and outreach programs for perinatal and postpartum women with substance use disorders to educate them on biological, emotional, and psychosocial milestones and struggles at each stage during pregnancy and the first 12 months following birth to reduce stress that could trigger a return to drug use or overdose.
OWH anticipates project periods of up to 3 years in annual budget periods. Recipients will be required to submit a non-competing continuation application for each budget period after the first. Funding for the budget periods after the first will be contingent upon availability of funding, satisfactory performance (including recipient progress towards meeting stated project milestones and goals, timely submission of required reports, and compliance with all grant terms and conditions), and the best interests of the government. OWH anticipates offering a competitive fourth year for the purpose of providing limited funding to support selected projects in their transition to sustainability.
Estimated Post Date: |
Mar 22, 2022 |
Estimated Application Due Date: |
Jun 01, 2022 |